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d Cartilage 22 (2014) S57–S489Conclusions: The pelvis would appear to remain the optimum site for
harvesting of bone marrow for use in single sitting procedures despite
the increased morbidity from harvesting at this site. Further work is
now being undertaken to establish the properties of MSCs from these
different sites in terms of their ability to differentiate into desired tis-
sues such as cartilage and bone.
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Osteoarthritis (OA) is a very common disease affecting a growing part of
aging population. It is a degenerative joint disease accompanied by
degradation of the articular cartilage and variable degrees of synovium
inﬂammation. Mesenchymal Stromal Cells (MSC) have generated sig-
niﬁcant medical consideration since they secrete immuno-modulatory
and anti-inﬂammatory factors. Unfortunately, the intra-articular injec-
tion of MSC suffers some major limitations including: (i) a massive cell
Abstracts / Osteoarthritis anS444death upon injection in the articular space making difﬁcult to detect the
injected cells for a sustained time; (ii) a risk of cell leak outside the
articular space due to the propensity of MSC to migrate.
Purpose: The present project is devoted to the development of a
therapeutic strategy for OA, based on the exploitation of the immuno-
modulatory properties of MSC. To overcome the limitations of the crude
intraarticular injections (cell death and leakage of MSC), we propose to
entrap bioactive MSC prior to their injection within cytoprotective and
permeable microcapsules made of innovative biomaterials.
Materials: Alginate and silylated hydroxypropyl methylcellulose (Si-
HPMC) were chosen as biocompatible biomaterials able to support the
viability and bioactivity of encapsulated MSC. MSC were isolated from
human adipose tissue (hADSC: human adipose tissue stromal cells).
We selected a dropwise method in CaCl2 solution to obtain alginate
capsules. To produce SI-HPMCmicrocapsules, we developed water in oil
(w/o) emulsion protocol with or without surfactant. To assess pore size
of microcapsules, the diffusion of FITC-dextranmolecules (sizes ranging
from 20 to 2000 KDa) through alginate and Si-HPMC microcapsules
were followed by confocal microscopy. For MSC encapsulation, a hADSC
suspension of 2.106 cells/ml was added either to the alginate solution or
to the Si-HPMC solution (without surfactant). The microbeads were
then collected by ﬁltration, washed with HEPES buffer and seeded in
culture medium. Culture medium was changed every 2 days after cell
encapsulation. hADSC viability after encapsulation in alginate and Si-
HPMC was followed for a period of 24 h to 2 months using a Live/Dead
Viability/Cytotoxicity kit.
Results: By dropwise method, we obtained alginate capsules with an
average size of 1,1 0,2 mm. Preliminary results have shown that their
pore size was between 10 nm and 21 nm.
With Si-HPMC, we managed to develop a suitable microencapsulation
method by varying operating parameters such as surfactant, temper-
ature or rotating speed. In optimal conditions, we obtained Si-HPMC
microbeads with a size of 50,3 4,9 mm (when a surfactant was used)
and 1 0,9 mm (without surfactant). Their pore size was ranging from
10 nm to 21 nm.
Thenwe encapsulated hADSC in both polymers. We detected a high rate
of viable encapsulated cells in 1 mm alginate capsules (about 93% of
viability at 2 months post-encapsulation). In addition, we observed a
lower rate of viable encapsulated hADSC in 1 mm Si-HPMC capsules
(less than 50% of viability at 48 h post-encapsulation).
Conclusions: Alginate and Si-HPMC appear as suitable biomaterials for
producing permeable microcapsules. Dropwise and emulsion methods
allow us to obtain capsules with different sizes. Our data strongly
suggest that capsule porosity is appropriate to maintain cell viability
(diffusion of nutrients and oxygen) and biological functions. Further
experiments are now under investigation to determine whether hADSC
encapsulated in permeable biomaterials may be a relevant strategy to
prevent cartilage degradation and inﬂammation in OA.
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Objective: Osteochondral defects is a very common and chanllenging
problem of orthopaedic surgery. The mature chondrocyte embedded in
the avascular (no blood vessels) and aneural (no neurons and nerves)
articular cartilage lacking of usual self-regeneration (the process of
repair by formation of the same type of tissue) after injury or disease.
Stromal stem cells (MSCs) aremultipotent cells and able to differenciate
into chondrocytes under certain culture medium (such as TGF-b, BMPs,
IGFs) and easily proliferate while maintaining their undifferentiated
state. Previous researches have proved that Wnt/b-catenin signaling
pathway is essential for stem cells self-renewal and chondrogenic dif-
ferenciation. In this study, we intend to investigate the transforming
growth factor-b1 (TGF-b1) on expression of Wnt signaling pathway
related genes during the chondrogenesis of bone marrow stem cells
(BMSCs) in vitro.
Methods: The BMSCs of immature SPF SD rat, isolated and cultured
with or without TGF-b1 (2ng/ml TGF-b1 medium containing 10% fetal
bovine serum) in vitro. Cultured cells were observed by inverted phase
contrast microscope and identiﬁed by toluidine blue staining. The
